Ibn Alhaytham Hospital (AMM:IBNH) YoY EBITDA Growth: -45.45% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:IBNH Ibn Alhaytham Hospital AMM:IBNH
33 GF Score
Price JOD0.86
GF Value JOD0.84
! 11 Warning Signs
View Full Analysis

What is Ibn Alhaytham Hospital YoY EBITDA Growth?

Ibn Alhaytham Hospital AMM:IBNH 33 YoY EBITDA Growth is -45.45% as of Jun. 2026. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.84. The stock has 11 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ibn Alhaytham Hospital's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -45.45%.

Ibn Alhaytham Hospital's EBITDA per Share for the three months ended in Jun. 2026 was JOD0.02.

Ibn Alhaytham Hospital YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Ibn Alhaytham Hospital's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ibn Alhaytham Hospital YoY EBITDA Growth Chart

Ibn Alhaytham Hospital Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.89 -123.75 36.84 941.67 10.89

Ibn Alhaytham Hospital Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.00 128.57 6.82 -11.76 -45.45
AMM:IBNH
33GF Score
Ibn Alhaytham Hospital AMM:IBNH
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ibn Alhaytham Hospital YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ibn Alhaytham Hospital's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.112-0.101)/ | 0.101 |
=10.89 %

Ibn Alhaytham Hospital's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.018-0.033)/ | 0.033 |
=-45.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -45.45% mean?
Ibn Alhaytham Hospital (AMM:IBNH) has a YoY EBITDA Growth of -45.45% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ibn Alhaytham Hospital and its competitors.
Is Ibn Alhaytham Hospital's YoY EBITDA Growth too high?
Ibn Alhaytham Hospital's current YoY EBITDA Growth is -45.45%. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's YoY EBITDA Growth compare to HCA and THC?
Ibn Alhaytham Hospital's YoY EBITDA Growth of -45.45% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ibn Alhaytham Hospital and its competitors. Ibn Alhaytham Hospital's current YoY EBITDA Growth is -45.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Ibn Alhaytham Hospital (AMM:IBNH) has a current YoY EBITDA Growth of -45.45%. The stock's GF Value™ is JOD0.84, compared to a current price of JOD0.86 — trading 2.4% above its estimated fair value. The current YoY EBITDA Growth is -45.45%. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current YoY EBITDA Growth is -45.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?

Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued. The current stock price of JOD0.86 is trading 2.4% above its estimated GF Value™ of JOD0.84.

Key valuation signals for AMM:IBNH:

  • YoY EBITDA Growth: -45.45%
  • GF Value™: JOD0.84 vs. price of JOD0.86 (2.4% above fair value)
  • GF Score™: 33/100 with 11 warning signs

No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ibn Alhaytham Hospital Business Description

Address Al-Madina Al-Monawara Street, Amman, JOR, 11194
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score

Get the complete analysis for AMM:IBNH

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD0.86
Price
JOD0.84
GF Value